Marked diurnal fluctuation and rest benefit in a patient with parkin mutation

Movement Disorders

Volumn 23, Issue 4, 2008, Pages 624-626

  Chung, Sun J ^a   Park, Hee K ^a   Ki, Chang Seok ^b   Kim, Mi J ^a   Lee, Myoung C ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; PARKIN; ROPINIROLE; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; RADIOPHARMACEUTICAL AGENT; TROPANE DERIVATIVE; UBIQUITIN PROTEIN LIGASE;

ADULT; ANAMNESIS; ARTICLE; BRADYKINESIA; CASE REPORT; CIRCADIAN RHYTHM; CLINICAL FEATURE; CONVERSION DISORDER; DISEASE COURSE; DYSTONIA; GAIT DISORDER; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HUMAN; LIMB TREMOR; MALE; MUTATIONAL ANALYSIS; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RIGIDITY; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; UNSTEADINESS; DIFFERENTIAL DIAGNOSIS; GENETICS; LETTER; METABOLISM; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; POINT MUTATION; PUTAMEN; VIDEORECORDING;

ADULT; CIRCADIAN RHYTHM; DIAGNOSIS, DIFFERENTIAL; DOPAMINE; DOPAMINE AGONISTS; GAIT DISORDERS, NEUROLOGIC; HUMANS; LEVODOPA; MALE; PARKINSONIAN DISORDERS; POINT MUTATION; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RADIOPHARMACEUTICALS; TROPANES; UBIQUITIN-PROTEIN LIGASES; VIDEOTAPE RECORDING;

EID: 47549114881     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21951     Document Type: Article

References (8)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
2. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset Parkinsonism. Brain 2003;126:1271-1278.
3. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-1292.
4. Hjermind LE, Johannsen LG, Blau N, et al. Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency? Mov Disord 2006;21:679-682.
5. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 2000;123: 1112-1121.
6. Bandmann O, Marsden CD, Wood NW. Atypical presentations of dopa-responsive dystonia. Adv Neurol 1998;78:283-290.
7. Nomura Y, Uetake K, Yukishita S, et al. Dystonias responding to levodopa and failure in biopterin metabolism. Adv Neurol 1998; 78:253-266.
8. McGeer EG, McGeer PL. Some characteristics of brain tyrosine hydroxylase. In: Mandel J, editor. New concepts in neurotransmitter regulation. New York: Plenum; 1973. p 53-68.